Shelley Chu

CIK: 0001895958

Transaction Breakdown

Open Market Buys (P)1 (25.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (50.0%)

Compensation grants

Other (G, F, J, C, D, …)1 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

ODTX

Odyssey Therapeutics, Inc.

Director

HLVX

HilleVax, Inc.

Director

Discretionary Trading P&L

Holdings

Transaction History (4 total)

ODTX
Odyssey Therapeutics, Inc.
May 11, 2026
Purchase(P)
Direct
11.1K shares at avg. $18.00$200K
HLVX
HilleVax, Inc.
Sep 17, 2025
Tender Offer(U)
Direct
17.2K shares-
HLVX
HilleVax, Inc.
Jun 23, 2025
Award(A)
Direct
17.2K shares-
HLVX
HilleVax, Inc.
Jun 6, 2024
Award(A)
Stock Option
Direct
22.5K shares-

		Type	Shares	Price		Ownership
May 11, 2026	ODTX Odyssey Therapeutics, Inc.	Purchase(P)	11,111	$18.00	$199,998	Direct
Sep 17, 2025	HLVX HilleVax, Inc.	Tender Offer(U)	17,199	-	-	Direct
Jun 23, 2025	HLVX HilleVax, Inc.	Award(A)	17,199	-	-	Direct
Jun 6, 2024	HLVX HilleVax, Inc.	Award(A) Stock Option	22,500	-	-	Direct

1-4 of 4 transactions

About Chu Shelley

Chu Shelley (SEC CIK 0001895958) files insider reports with the SEC as Director of Odyssey Therapeutics, Inc. (ODTX) and Director of HilleVax, Inc. (HLVX).

Signal8 holds 5 ownership filings by Chu Shelley (1 Form 3, 4 Form 4), filed between Apr 30, 2025 and May 11, 2026. Those filings report 4 transactions, from Jun 6, 2024 to May 11, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Chu Shelley's filings is in BOSTON, MA.

Recent filings by Chu Shelley

May 11, 2026: Open-market purchase of ODTX shares (Form 4, code P).
Sep 17, 2025: Tender of shares transaction of HLVX shares (Form 4, code U).
Jun 23, 2025: Grant or award of HLVX shares (Form 4, code A).
Jun 6, 2024: Grant or award of HLVX derivative securities (Form 4, code A).

Other insiders filing for Odyssey Therapeutics, Inc. (ODTX)

TPG GP A, LLC, Officer
Dimension Capital II, L.P., Director
SR ONE CAPITAL MANAGEMENT, LLC, 10% Owner
LEIDEN JEFFREY M, Director
Haas Jason, Chief Financial Officer
Li Nan (LN), Director

How to read Form 4 transaction codes